• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESPIRONICS INC. PHILIPS RESPIRONICS CPAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESPIRONICS INC. PHILIPS RESPIRONICS CPAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Dyspnea (1816); Lymphoma (3263); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 04/20/2022
Event Type  Injury  
Event Description
I had been having shortness of breath problems that began as mild in early 2021.After undergoing several cardiac and pulmonary tests including an angiography, nothing was revealed as the cause of the sob.In (b)(6) 2022, i began experiencing more frequent sob episodes.In (b)(6) 2022, the progression of deterioration became rapid.By the last half of (b)(6) each week i saw a significant decline in my ability to breathe with any kind of effort.On (b)(6) 2022, i was forced to retire from my part time job because i could not perform the activities required of me as a physical therapist.By the middle of (b)(6), i could not walk 10 feet without becoming sob and requiring to stop, i could not lay flat, and it took me a prolonged time to do simple self-care activities such as showering and dressing.On (b)(6) 2022, i was hospitalized with l lung pleurisy and 3 liters of fluid was drained from that lung.Additional thoracentesis were required from (b)(6) 2022.Tests on the fluid removed at the time of the (b)(6) thoracentesis revealed possible cancer cells.At the end of (b)(6), additional tests including ct and pet scans confirmed that i have an uncurable non-hodgkin's lymphoma.It began in the lung lymph and had spread to other lymph nodes in the upper and lower body segments.In (b)(6) 2022, i began a chemo treatment series.That initial series has been completed and will be followed by a less frequent chemo treatment administration until it is no longer effective.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHILIPS RESPIRONICS CPAP
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
RESPIRONICS INC.
MDR Report Key16832903
MDR Text Key314294375
Report NumberMW5117113
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 04/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Patient Sequence Number1
Patient Outcome(s) Disability; Hospitalization;
Patient Age73 YR
Patient SexFemale
Patient Weight73 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-